全文获取类型
收费全文 | 2736篇 |
免费 | 124篇 |
国内免费 | 9篇 |
专业分类
耳鼻咽喉 | 19篇 |
儿科学 | 30篇 |
妇产科学 | 52篇 |
基础医学 | 277篇 |
口腔科学 | 65篇 |
临床医学 | 177篇 |
内科学 | 775篇 |
皮肤病学 | 66篇 |
神经病学 | 231篇 |
特种医学 | 172篇 |
外科学 | 426篇 |
综合类 | 13篇 |
预防医学 | 92篇 |
眼科学 | 30篇 |
药学 | 83篇 |
中国医学 | 1篇 |
肿瘤学 | 360篇 |
出版年
2024年 | 4篇 |
2023年 | 28篇 |
2022年 | 63篇 |
2021年 | 106篇 |
2020年 | 50篇 |
2019年 | 47篇 |
2018年 | 83篇 |
2017年 | 57篇 |
2016年 | 70篇 |
2015年 | 81篇 |
2014年 | 104篇 |
2013年 | 136篇 |
2012年 | 235篇 |
2011年 | 195篇 |
2010年 | 110篇 |
2009年 | 107篇 |
2008年 | 156篇 |
2007年 | 179篇 |
2006年 | 142篇 |
2005年 | 182篇 |
2004年 | 135篇 |
2003年 | 139篇 |
2002年 | 126篇 |
2001年 | 30篇 |
2000年 | 39篇 |
1999年 | 38篇 |
1998年 | 29篇 |
1997年 | 23篇 |
1996年 | 25篇 |
1995年 | 18篇 |
1994年 | 12篇 |
1993年 | 8篇 |
1992年 | 14篇 |
1991年 | 12篇 |
1990年 | 6篇 |
1989年 | 7篇 |
1988年 | 6篇 |
1987年 | 11篇 |
1986年 | 7篇 |
1985年 | 7篇 |
1984年 | 9篇 |
1982年 | 2篇 |
1981年 | 5篇 |
1980年 | 2篇 |
1977年 | 3篇 |
1974年 | 4篇 |
1971年 | 3篇 |
1955年 | 1篇 |
1917年 | 1篇 |
1914年 | 1篇 |
排序方式: 共有2869条查询结果,搜索用时 15 毫秒
61.
62.
Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis 总被引:9,自引:0,他引:9
Sato S Hirakata M Kuwana M Suwa A Inada S Mimori T Nishikawa T Oddis CV Ikeda Y 《Arthritis and rheumatism》2005,52(5):1571-1576
OBJECTIVE: To identify novel autoantibodies specific for dermatomyositis (DM), especially those specific for clinically amyopathic DM (C-ADM). METHODS: Autoantibodies were analyzed by immunoprecipitation in 298 serum samples from patients with various connective tissue diseases (CTDs) or idiopathic pulmonary fibrosis (IPF). Antigen specificity of the sera was further examined by immunoblotting and indirect immunofluorescence (IF). The disease specificity and clinical features associated with the antibody of interest were determined. RESULTS: Eight sera recognized a polypeptide of approximately 140 kd (CADM-140 autoantigen) by immunoprecipitation and immunoblotting. Immunoreactivity was detected in the cytoplasm, and indirect IF revealed a granular or reticular pattern. Anti-CADM-140 antibodies were detected in 8 of 42 patients with DM, but not in patients with other CTDs or IPF. Interestingly, all 8 patients with anti-CADM-140 antibodies had C-ADM. Among 42 patients with DM, those with anti-CADM-140 autoantibodies had significantly more rapidly progressive interstitial lung disease (ILD) when compared with patients without anti-CADM-140 autoantibodies (50% versus 6%; P = 0.008). CONCLUSION: These results indicate that the presence of anti-CADM-140 autoantibodies may be a novel marker for C-ADM. Further attention should be directed to the detection of rapidly progressive ILD in those patients with anti-CADM-140 autoantibodies. 相似文献
63.
64.
65.
Noriyuki Watanabe Kiyoko Kobayashi Sachie Koyama Mayu Tabira Junpei Matsuno Yoshitada Taji Yu Akuzawa Maho Ishikawa Tomoya Maeda Kazuo Imai Norihito Tarumoto Norio Asou Kotaro Mitsutake Yasuhiro Ebihara 《Transplant infectious disease》2020,22(2)
We reported the case of a patient with leukemia who developed febrile neutropenia after hematopoietic stem cell transplantation. Blood culture results revealed the presence of Streptococcus oralis, while antimicrobial susceptibility testing showed the resistance to penicillin and cephem. Furthermore, isolates were not susceptible to either meropenem or daptomycin but not to vancomycin. S oralis is known to belong to Streptococcus mitis group and be a causative agent of bacteremia in the neutropenic patients, but multidrug resistance of S oralis is rare. Our findings suggest that we might pay attention to the emergence of the microorganisms acquiring multidrug resistance in neutropenic patients. 相似文献
66.
Functional engraftment of human peripheral T and B cells and sustained production of autoantibodies in NOD/LtSzscid/IL‐2Rγ−/− mice 下载免费PDF全文
Yuki Ishikawa Takashi Usui Aoi Shiomi Masakazu Shimizu Kosaku Murakami Tsuneyo Mimori 《European journal of immunology》2014,44(11):3453-3463
NOD/LtSzscid/IL‐2Rγ?/? (NSG) mice have advantages in establishing humanized mouse models. However, transferring human PBMCs into these mice often causes lethal GVH disease. In this study, we discovered an improved method for the engraftment of normal or pathological human PBMCs into NSG mice and examined the subsequent induction of specific immune responses. We sequentially transferred human CD4+ memory T (Tm) and B cells obtained from PBMCs of healthy adults or patients with autoimmune diseases into NSG mice. Removing naïve CD4+ T cells from the transferred PBMCs allowed successful engraftment without lethal GVH disease. The transferred Tm cells were found to reside mainly in the spleen and the lymphoid nodules, where they expressed MHC class II molecules and produced cytokines, including IL‐21. Surprisingly, the transferred B cells were also well maintained in the lymphoid organs, underwent de novo class‐switch recombination, and secreted all isotypes of human Igs at significant levels. Moreover, transferring patient‐derived Tm and B cells resulted in sustained production of IgM‐rheumatoid factor and antiaminoacyl transfer RNA synthetase Abs in these mice. These results suggest that transfer of Tm and B cells derived from human PBMCs into NSG mice could be a useful method for the study of human autoimmune mechanisms. 相似文献
67.
Prolyl hydroxylase domain (PHD) proteins catalyze oxygen-dependent prolyl hydroxylation of hypoxia-inducible factor 1α and 2α, tagging them for pVHL-dependent polyubiquitination and proteasomal degradation. In this study, albumin Cre (AlbCre)–mediated, hepatocyte-specific triple disruption of Phd1, Phd2, and Phd3 (Phd(1/2/3)hKO) promoted liver erythropoietin (EPO) expression 1246-fold, whereas renal EPO was down-regulated to 6.7% of normal levels. In Phd(1/2/3)hKO mice, hematocrit levels reached 82.4%, accompanied by severe vascular malformation and steatosis in the liver. In mice double-deficient for hepatic PHD2 and PHD3 (Phd(2/3)hKO), liver EPO increase and renal EPO loss both occurred but were much less dramatic than in Phd(1/2/3)hKO mice. Hematocrit levels, vascular organization, and liver lipid contents all appeared normal in Phd(2/3)hKO mice. In a chronic renal failure model, Phd(2/3)hKO mice maintained normal hematocrit levels throughout the 8-week time course, whereas floxed controls developed severe anemia. Maintenance of normal hematocrit levels in Phd(2/3)hKO mice was accomplished by sensitized induction of liver EPO expression. Consistent with such a mechanism, liver HIF-2α accumulated to higher levels in Phd(2/3)hKO mice in response to conditions causing modest systemic hypoxia. Besides promoting erythropoiesis, EPO is also known to modulate retinal vascular integrity and neovascularization. In Phd(1/2/3)hKO mice, however, neonatal retinas remained sensitive to oxygen-induced retinopathy, suggesting that local EPO may be more important than hepatic and/or renal EPO in mediating protective effects in the retina.Prolyl hydroxylase domain (PHD) proteins PHD1, PHD2, and PHD3 use molecular oxygen as a substrate to hydroxylate specific prolyl residues in HIF-1α and HIF-2α,1–3 tagging them for von Hippel–Lindau protein (pVHL)–dependent polyubiquitination and proteasomal degradation.4 PHD-regulated HIF-α stability is important for multiple processes, including angiogenesis,5–7 erythropoiesis,8–10 cardiomyocyte function,11–13 cell survival,14 and metabolism.15 PHD1 and PHD2 also hydroxylate IKKβ, thus regulating the assembly of NF-κB and functions of monocytic cells and proangiogenic macrophages.16–19 Besides PHDs, a transmembrane prolyl hydroxylase in the endoplasmic reticulum (P4H-TM) may also regulate HIF-α stability.20,21In normal adults, renal interstitial cells are responsible for the bulk of plasma erythropoietin (EPO) and thus play a key role in regulating erythropoiesis and blood homeostasis. Loss or dysfunction of renal interstitial cells due to acute renal injury or chronic kidney disease can lead to EPO deficiency and severe anemia.22 Normal liver expresses EPO only at very low levels, but possesses latent capacity for EPO expression that can be reactivated by manipulations that lead to hepatic HIF-2α stabilization. For example, hepatocyte-specific Vhl knockout in mice resulted in the accumulation of HIF-1α and HIF-2α to high levels, and subsequent studies showed that HIF-2α was responsible for elevated liver EPO expression and polycythemia.23,24 Other studies have also demonstrated critical roles of HIF-2α in regulating EPO expression.25,26Our research group has previously shown that germline Phd1 and Phd3 double knockout leads to increased liver EPO expression.8 In a more recent study, Minamishima and Kaelin27 showed that more dramatic liver EPO up-regulation can be induced by triple Phd knockout, with Phd1 and Phd3 knockout being germline null mutations and Phd2 knockout induced in a hepatocyte-restricted manner. These studies raised the possibility that the liver may be exploited as an alternative source for endogenous EPO production in case of renal failure. Indeed, siRNA-mediated knockdown of hepatic PHD rescued erythropoiesis in mice subjected to 5/6 nephrectomy.28 Although these findings are highly encouraging, it is not known how the liver itself is affected by PHD deficiency.In the present study, we examined hematological effects of hepatic PHD deficiency in an established chronic renal failure model,29–32 and compared blood, vascular, and lipid phenotypes associated with the disruption of different combinations of PHD isoforms in the liver. Hepatic triple deficiency of all three isoforms caused multiple abnormalities, including severe erythrocytosis, vascular malformation, and massive lipid accumulation in the liver. By contrast, mice double-deficient for hepatic PHD2 and PHD3 did not exhibit any of these defects, but yet gained the ability to maintain normal hematocrit (Hct) levels in a chronic renal failure model. These data provide the proof of principle that selective combinations of hepatic PHD isoforms could offer suitable therapeutic targets for maintaining normal blood homeostasis without accompanying vascular malformation or liver steatosis. 相似文献
68.
69.
Takagi H Yamamoto H Iwata K Goto SN Umemoto T;ALICE 《International journal of cardiology》2012,159(3):230-233